» Articles » PMID: 23355956

Increased Survivin Expression Contributes to Apoptosis-resistance in IPF Fibroblasts

Overview
Date 2013 Jan 29
PMID 23355956
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Fibroblasts perform critical functions during the normal host response to tissue injury, but the inappropriate accumulation and persistent activation of these cells results in the development of tissue fibrosis. The mechanisms accounting for the aberrant accumulation of fibroblasts during fibrotic repair are poorly understood, although evidence supports a role for fibroblast resistance to apoptosis as a contributing factor. We have shown that TGF-β1 and endothelin-1 (ET-1), soluble mediators implicated in fibrogenesis, promote fibroblast resistance to apoptosis. Moreover, we recently found that ET-1 induced apoptosis resistance in normal lung fibroblasts through the upregulation of survivin, a member of the Inhibitor of Apoptosis (IAP) protein family. In the current study, we sought to determine the role of survivin in the apoptosis resistance of primary fibroblasts isolated from the lungs of patients with Idiopathic Pulmonary Fibrosis (IPF), a fibrotic lung disease of unclear etiology for which there is no definitive therapy. First, we examined survivin expression in lung tissue from patients with IPF and found that there is robust expression in the fibroblasts residing within fibroblastic foci (the "active" lesions in IPF which correlate with mortality). Next, we show that survivin expression is increased in fibroblasts isolated from IPF lung tissue compared to cells from normal lung tissue. Consistent with a role in fibrogenesis, we demonstrate that TGF-β1 increases survivin expression in normal lung fibroblasts. Finally, we show that inhibition of survivin enhances susceptibility of a subset of IPF fibroblasts to apoptosis. Collectively, these findings suggest that increased survivin expression represents one mechanism contributing an apoptosis-resistant phenotype in IPF fibroblasts.

Citing Articles

Discoidin domain receptor 2 signaling through PIK3C2α in fibroblasts promotes lung fibrosis.

Ling S, Kwak D, Takuwa Y, Ge C, Franceschi R, Kim K J Pathol. 2024; 262(4):505-516.

PMID: 38332727 PMC: 10940211. DOI: 10.1002/path.6253.


Genetic deficiency of the transcription factor NFAT1 confers protection against fibrogenic responses independent of immune influx.

Vittal R, Walker N, McLinden A, Braeuer R, Ke F, Fattahi F Am J Physiol Lung Cell Mol Physiol. 2023; 326(1):L39-L51.

PMID: 37933452 PMC: 11279780. DOI: 10.1152/ajplung.00045.2023.


Regulation of Mesenchymal Cell Fate by Transfer of Active Gasdermin-D via Monocyte-Derived Extracellular Vesicles.

Sarkar A, Das S, Bone H, DeVengencie I, Prasad J, Farkas D J Immunol. 2023; 210(6):832-841.

PMID: 36688687 PMC: 9998362. DOI: 10.4049/jimmunol.2200511.


Human Cytomegalovirus and Human Herpesvirus 6 Coinfection of Dermal Fibroblasts Enhances the Pro-Inflammatory Pathway Predisposing to Fibrosis: The Possible Impact on Systemic Sclerosis.

Soffritti I, DAccolti M, Maccari C, Bini F, Mazziga E, De Conto F Microorganisms. 2022; 10(8).

PMID: 36014018 PMC: 9415275. DOI: 10.3390/microorganisms10081600.


Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option.

Korfei M, Mahavadi P, Guenther A Cells. 2022; 11(10).

PMID: 35626663 PMC: 9139813. DOI: 10.3390/cells11101626.


References
1.
Altieri D . Survivin and IAP proteins in cell-death mechanisms. Biochem J. 2010; 430(2):199-205. PMC: 3198835. DOI: 10.1042/BJ20100814. View

2.
Andersen M, Marie Svane I, Becker J, Straten P . The universal character of the tumor-associated antigen survivin. Clin Cancer Res. 2007; 13(20):5991-4. DOI: 10.1158/1078-0432.CCR-07-0686. View

3.
Horowitz J, Thannickal V . Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy. Treat Respir Med. 2006; 5(5):325-42. PMC: 2231521. DOI: 10.2165/00151829-200605050-00004. View

4.
Ley B, Collard H, King Jr T . Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2010; 183(4):431-40. DOI: 10.1164/rccm.201006-0894CI. View

5.
Guha M, Altieri D . Survivin as a global target of intrinsic tumor suppression networks. Cell Cycle. 2009; 8(17):2708-10. PMC: 2819076. DOI: 10.4161/cc.8.17.9457. View